About Alzheon
Alzheon is a clinical-stage biopharmaceutical company that develops therapies for Alzheimer’s disease and other neurodegenerative disorders. It creates oral small-molecule candidates designed to target amyloid aggregation. Alzheon's customers are patients suffering from these diseases.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $100,000,000 · Series-B+
startupintros.com
- Milestone
X account created (@Alzheon)
471 followers
- Capital Raise
Raised $10,000,000 · Series-A
startupintros.com
- Milestone
Website domain registered
alzheon.com
- Milestone
Company founded
Framingham, United States
Investors & Backers
Funding History
Founders & Leadership
Aidan Power
Chief Development Officer
Dina Lynch
Vice President of Market Access
John Hey
Chief Scientific Officer
Ken Mace
Chief Financial Officer
Martin Tolar
founder
Nate Greene
Vice President of Brand Marketing
Susan Abushakra
Chief Medical Officer
Yasemin Khakian
Chief of Staff
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com